The American Journal of Managed Care’s ACO Coalition, now at 100 members, gives healthcare leaders a way to share ideas for improving population health. A recent Web-based exchange involving Mount Sinai ACO’s diabetes strategy showed how the initiative is working to spread good ideas across the country.
This model analysis explores the budget impact of prescribing single-pill fixed dose versus loose-dose combination triple therapies for hypertension.
Controlling for baseline characteristics, saxagliptin patients had lower medical costs compared with sulfonylurea patients, and lower medical and total costs than sitagliptin patients.
We characterized the direct cost of stage 4 non-small cell lung cancer from 2000 to 2009, with a focus on drug treatments.
This study compares the initiation of asthma therapies in a real-world population.
In the new issue of Evidence-Based Oncology, Ellen T. Matloff, MS, CGC, and Rachel E. Barnett, MS, CGC, of the Yale Cancer Center and Robert Nussbaum, MD, of UC San Francisco write that efforts by some genetic testing laboratories to grab market share in the lucrative BRCA testing market may put patients at risk, while violating ethical standards issued by the American Medical Association.
Medications with once-daily dosing are associated with better adherence than those with twice-daily dosing. Simplifying dosing frequency provides opportunity to improve medication adherence in NVAF patients.
This retrospective study compares treatment adherence and healthcare costs for primary immunodeficiency patients receiving intravenous immunoglobulin in home and outpatient settings.

Issue List